Our results also show that participants with AH, T2DM, MetS and high PhA values were almost twice as likely to use insulin than those with low PhA values, whereas the duration of T2DM treatment was not significantly different between the groups. This evidence concerns the gene INS and type 2 diabetes mellitus.